W2O symplur

News

W2O has chalked up its fifth acquisition in less than a year with a deal to buy healthcare social media analytics company Symplur.

News

Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq as it advances its spin on CRISPR-based therapeutics.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.